Not applicableNo Longer AvailableNCT04087876
What this trial is testing
Expanded Access Use of Derazantinib for Advanced Intrahepatic Cholangiocarcinoma (iCCA) With FGFR Genomic Alterations
Who this might be right for
Intrahepatic Cholangiocarcinoma
Basilea Pharmaceutica